Next report date
Report period
Q1 2024
EPS estimate
−0.09EUR
Revenue estimate
662.37 KEUR
−0.4305EUR
−16.82 MEUR
33.57 M
About FSD PHARMA INC. SUBORDINATE VOTING SHARES
Sector
Industry
CEO
Zeeshan Saeed
Website
Headquarters
Toronto
Founded
1994
FIGI
BBG00LPDYRJ0
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange FSD PHARMA B stocks are traded under the ticker 0K9.
FSD PHARMA B is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
0K9 earnings for the last quarter are −0.03 EUR per share, whereas the estimation was −0.13 EUR resulting in a 78.53% surprise. The estimated earnings for the next quarter are −0.13 EUR per share. See more details about FSD PHARMA B earnings.
FSD PHARMA B revenue for the last quarter amounts to 8.87 K EUR despite the estimated figure of 277.55 K EUR. In the next quarter revenue is expected to reach 187.42 K EUR.
Yes, you can track FSD PHARMA B financials in yearly and quarterly reports right on TradingView.
0K9 net income for the last quarter is −1.54 M EUR, while the quarter before that showed −1.06 M EUR of net income which accounts for −45.54% change. Track more FSD PHARMA B financial stats to get the full picture.
No, 0K9 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0K9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FSD PHARMA B stock right from TradingView charts — choose your broker and connect to your account.